Related Experiment Video

Updated: Aug 7, 2026

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

Exenatide inhibits beta-cell apoptosis by decreasing thioredoxin-interacting protein

Junqin Chen1, Francesca M Couto, Alexandra H Minn

  • 1Department of Medicine, University of Wisconsin, Madison, WI 53792, USA.

Biochemical and Biophysical Research Communications
|June 20, 2006
PubMed

Insights

Exenatide (Ex-4) protects beta-cells from oxidative stress by reducing thioredoxin-interacting protein (TXNIP). This mechanism preserves beta-cell mass, potentially delaying type 2 diabetes progression.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Pharmacology

Background:

  • Exenatide (Ex-4) is an anti-diabetic drug known to stimulate insulin secretion and enhance beta-cell mass.
  • The precise mechanisms underlying Ex-4's effects on beta-cells, particularly concerning oxidative stress and apoptosis, remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which Ex-4 protects beta-cells from oxidative stress-induced apoptosis.
  • To investigate the role of thioredoxin-interacting protein (TXNIP) in Ex-4's protective effects.

Main Methods:

  • Utilized INS-1 beta-cells, mouse, and human islets, along with wild-type mice.
  • Assessed apoptosis using TUNEL assay.
  • Measured expression levels of TXNIP, caspase-3, and Bax via mRNA and protein analysis.
  • Created stable TXNIP-overexpressing INS-1 cell lines to evaluate the necessity of TXNIP reduction.

Main Results:

  • Exenatide (Ex-4) demonstrated protective effects against oxidative stress-induced apoptosis in beta-cells.
  • Ex-4 significantly reduced the expression of TXNIP, a pro-apoptotic factor implicated in beta-cell toxicity.
  • This reduction in TXNIP was observed across various models, including cell lines, human islets, and in vivo in mice.
  • Downstream apoptotic markers, caspase-3 and Bax, were also decreased following Ex-4 treatment.
  • Overexpression of TXNIP in INS-1 cells abrogated the anti-apoptotic effects of Ex-4, confirming TXNIP's critical role.

Conclusions:

  • Exenatide (Ex-4) inhibits beta-cell apoptosis primarily by downregulating TXNIP expression.
  • Early intervention with Ex-4 may be a viable strategy to preserve beta-cell function and mass.
  • These findings suggest Ex-4's potential to protect against oxidative stress and slow the progression of type 2 diabetes.

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...